Clinical and pathological parameters of female dogs with MC-BMT and correlation with the presence (+) or absence (-) of LDN treatment.</p
Patient characteristics of dogs receiving EBRT/TRT/IT-IC combination protocol.</p
<p>Comparison of costimulatory molecules in dogs with localized and disseminated histiocytic sarcoma...
<p>Comparison of costimulatory molecules in dogs in the other tumor group with or without metastasis...
Data are expressed as means of the quality of life scores for each group. *Significant differences b...
*Significant differences at p < 0.05, according to the Kruskal-Wallis statistical test.</p
Hematologic parameters in female dogs with carcinoma in benign mixed tumor, stratified as before and...
Hematologic parameters in female dogs with carcinoma in benign mixed tumor, divided before and after...
The clinical characteristics and prescribed cardiovascular drugs of dogs in the control, DMVD and DM...
Serum biochemical parameters in female dogs with carcinoma in benign mixed tumor, stratified as befo...
<p>Sex, age, anatomic localization of the lesions, morphological diagnosis in dogs suffering SRMA, I...
Demographic Features, Clinical Characteristics and Response to Treatment of Dogs with Canine Tegumen...
<p>Haematological and biochemical parameters of 28 dogs with leishmaniasis and CKD before (at day 0)...
<p>Results of selected clinical pathological variables assessed in 12 dogs that were diagnosed with ...
Outcome parameters for dogs with lung tumors based on maximum tumor diameter and volume.</p
(A) Total grading scores of clinical manifestation and (B) spontaneous locomotor activity at differe...
Patient characteristics of dogs receiving EBRT/TRT/IT-IC combination protocol.</p
<p>Comparison of costimulatory molecules in dogs with localized and disseminated histiocytic sarcoma...
<p>Comparison of costimulatory molecules in dogs in the other tumor group with or without metastasis...
Data are expressed as means of the quality of life scores for each group. *Significant differences b...
*Significant differences at p < 0.05, according to the Kruskal-Wallis statistical test.</p
Hematologic parameters in female dogs with carcinoma in benign mixed tumor, stratified as before and...
Hematologic parameters in female dogs with carcinoma in benign mixed tumor, divided before and after...
The clinical characteristics and prescribed cardiovascular drugs of dogs in the control, DMVD and DM...
Serum biochemical parameters in female dogs with carcinoma in benign mixed tumor, stratified as befo...
<p>Sex, age, anatomic localization of the lesions, morphological diagnosis in dogs suffering SRMA, I...
Demographic Features, Clinical Characteristics and Response to Treatment of Dogs with Canine Tegumen...
<p>Haematological and biochemical parameters of 28 dogs with leishmaniasis and CKD before (at day 0)...
<p>Results of selected clinical pathological variables assessed in 12 dogs that were diagnosed with ...
Outcome parameters for dogs with lung tumors based on maximum tumor diameter and volume.</p
(A) Total grading scores of clinical manifestation and (B) spontaneous locomotor activity at differe...
Patient characteristics of dogs receiving EBRT/TRT/IT-IC combination protocol.</p
<p>Comparison of costimulatory molecules in dogs with localized and disseminated histiocytic sarcoma...
<p>Comparison of costimulatory molecules in dogs in the other tumor group with or without metastasis...